{{Rsnum
|rsid=11979158
|Gene=EGFR
|Chromosome=7
|position=55091656
|Orientation=plus
|GMAF=0.1593
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=EGFR
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 67.3 | 29.2 | 3.5
| HCB | 98.5 | 1.5 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 40.8 | 51.7 | 7.5
| ASW | 50.9 | 42.1 | 7.0
| CHB | 98.5 | 1.5 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 92.1 | 7.9 | 0.0
| LWK | 59.1 | 32.7 | 8.2
| MEX | 67.2 | 31.0 | 1.7
| MKK | 70.5 | 28.8 | 0.6
| TSI | 79.4 | 18.6 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21531791
|Trait=None
|Title=Chromosome 7p11.2 (EGFR) variation influences glioma risk.
|RiskAllele=A
|Pval=7E-8
|OR=1.2300
|ORtxt=[1.15-1.35]
|OA=1
}}

Associated with [[glioma]] risk.

{{PMID|21825990}} Genetic causes of glioma: new leads in the labyrinth.

{{PMID Auto
|PMID=23236348
|Title=EGFR Gene Variants Are Associated with Specific Somatic Aberrations in Glioma
|OA=1
}}

{{PMID Auto
|PMID=23161787
|Title=Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}